Is Pregnancy Safe With PNH? Risks, Treatment, and Care

Pregnancy with paroxysmal nocturnal hemoglobinuria (PNH) is possible, but it is considered high-risk. While many women with PNH have successful pregnancies, the condition increases the risk of serious complications for both the mother and the baby ^[1]. Your individual risk depends heavily on how well your PNH is currently controlled, your history of blood clots, your platelet counts, and your kidney function.

Because of the complexities involved, never stop or change your PNH medications on your own, especially if you discover an unplanned pregnancy. Always contact your treating team immediately for guidance.

Before Trying to Conceive

If you are planning to become pregnant, a preconception visit is strongly recommended ^[2]. Because PNH is an acquired condition, it is not typically passed genetically to your baby. During this planning phase, your medical team will:

• Review your current health: Assess your recent blood counts, kidney function, and history of blood clots or bleeding.
• Review your medications: Ensure your treatments are safe for pregnancy.
• Check vaccinations: Verify that your meningococcal vaccines are up to date, which is critical if you are taking complement inhibitors ^[3][4].

Why is a PNH Pregnancy High-Risk?

Pregnancy naturally increases the stress on the body and changes how blood clots. When combined with PNH, these changes amplify several risks:

• Blood Clots (Thrombosis): PNH already carries a high risk of blood clots. Pregnancy and the postpartum period add to this, making thrombosis a serious, life-threatening concern ^[5][6].
• Breakthrough Hemolysis: The sudden destruction of red blood cells (hemolysis) can flare up during pregnancy, even if your PNH was previously well-controlled ^[7][8]. Symptoms can include worsening fatigue, dark urine, or abdominal pain.
• Maternal Complications: Women with PNH are at a higher risk for pre-eclampsia (pregnancy-related high blood pressure that can affect organs like the kidneys) and bleeding complications, particularly if they have a low platelet count (thrombocytopenia) ^[9][10].
• Fetal Risks: PNH pregnancies have higher rates of premature birth, miscarriage, and restricted fetal growth (where the baby is smaller than expected) ^[9][11].

Emergency Warning Signs

Because complications can develop rapidly, seek immediate emergency medical care if you experience:

• Sudden shortness of breath or chest pain
• Swelling, warmth, or pain in one leg
• Markedly dark urine or rapidly worsening fatigue
• Severe abdominal or back pain
• Heavy bleeding
• Severe headache or changes in your vision
• Decreased fetal movement

Building Your Care Team

Your care must be planned jointly by a hematologist who is experienced in treating PNH and a high-risk OB-GYN, known as a Maternal-Fetal Medicine (MFM) specialist ^[2][8]. While your usual obstetrician may remain part of the team, an obstetric anesthesiologist should also be involved early to plan for delivery ^[2].

Treatment Adjustments During Pregnancy

If you become pregnant, your care team will closely monitor you and may adjust your treatments:

• Complement Inhibitors: Medications like eculizumab are commonly used during pregnancy to control PNH. Observational studies show that treated pregnancies have better outcomes, such as a fetal survival rate of 82% compared to 69% in untreated pregnancies, alongside fewer miscarriages ^[9]. However, this is not a guarantee of a complication-free pregnancy. Eculizumab has a larger evidence base in pregnancy, while data for newer drugs like ravulizumab are more limited, though observational reports of successful live births exist ^[12]. Because pregnancy alters complement activity and how your body clears drugs, doctors will closely monitor your labs (like LDH levels) and symptoms. Dose increases or more frequent infusions are often necessary to prevent breakthrough hemolysis ^[11][13].
• Blood Thinners (Anticoagulants): To counter the severe risk of blood clots, doctors commonly consider prescribing injectable blood thinners, such as low-molecular-weight heparin (LMWH) ^[6]. While heavily utilized (one observational cohort noted 88% of pregnant PNH patients used them ^[11]), the decision to use them, the dosage, and the duration are highly individualized. Your team will weigh your risk of clots against your risk of bleeding, especially if your platelet counts are low.
• Blood Transfusions: Some women require more red blood cell transfusions during pregnancy to treat clinically significant maternal anemia ^[11][7]. If your platelet counts drop or if you have active bleeding, platelet transfusions may also be necessary, particularly around delivery ^[11][14].

Delivery and The Postpartum Period

Delivery requires careful coordination. Your team will establish a timeline for when to pause blood thinners before labor or a cesarean delivery, which directly impacts your eligibility for an epidural ^[2]. The mode of delivery is based on obstetric indications and your overall health, not just PNH.

The days and weeks immediately following delivery (the postpartum period) are the most dangerous time for blood clots in women with PNH ^[11]. Even with preventive care, severe clots can still occur after birth ^[15]. Doctors often recommend continuing prophylactic blood thinners for approximately six weeks postpartum, though the exact duration and dose will be carefully tailored to your specific bleeding risks and platelet counts ^[16][17].

Breastfeeding

If you are taking eculizumab, available evidence suggests the medication is undetectable or minimal in breast milk, and no infant harm has been established in these reports ^[11][1]. Data for other medications like ravulizumab are much more limited. You should review your complete medication list with your hematologist, obstetrician, and pediatrician to make an informed choice about breastfeeding and infant monitoring.